A detailed history of Capital Advisors Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Capital Advisors Inc holds 7,388 shares of MRK stock, worth $732,741. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,388
Previous 7,516 1.7%
Holding current value
$732,741
Previous $930,000 9.89%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$111.15 - $128.97 $14,227 - $16,508
-128 Reduced 1.7%
7,388 $838,000
Q2 2024

Jul 31, 2024

BUY
$123.8 - $132.96 $24,883 - $26,724
201 Added 2.75%
7,516 $930,000
Q1 2024

Apr 29, 2024

BUY
$113.24 - $131.95 $35,670 - $41,564
315 Added 4.5%
7,315 $965,000
Q4 2023

Jan 29, 2024

SELL
$100.18 - $109.02 $10,719 - $11,665
-107 Reduced 1.51%
7,000 $763,000
Q3 2023

Oct 24, 2023

SELL
$102.95 - $114.33 $4,220 - $4,687
-41 Reduced 0.57%
7,107 $731,000
Q2 2023

Jul 18, 2023

BUY
$108.61 - $118.38 $51,589 - $56,230
475 Added 7.12%
7,148 $824,000
Q1 2023

Apr 19, 2023

SELL
$102.94 - $114.86 $97,690 - $109,002
-949 Reduced 12.45%
6,673 $709,000
Q4 2022

Jan 17, 2023

SELL
$87.44 - $112.11 $5,333 - $6,838
-61 Reduced 0.79%
7,622 $0
Q3 2022

Oct 17, 2022

SELL
$84.53 - $94.96 $9,890 - $11,110
-117 Reduced 1.5%
7,683 $661,000
Q2 2022

Jul 15, 2022

SELL
$83.49 - $94.64 $80,233 - $90,949
-961 Reduced 10.97%
7,800 $711,000
Q1 2022

May 05, 2022

SELL
$73.51 - $82.4 $105,560 - $118,326
-1,436 Reduced 14.08%
8,761 $719,000
Q4 2021

Jan 27, 2022

BUY
$72.28 - $90.54 $253,558 - $317,614
3,508 Added 52.44%
10,197 $781,000
Q3 2021

Oct 25, 2021

SELL
$71.68 - $78.83 $430 - $472
-6 Reduced 0.09%
6,689 $502,000
Q2 2021

Aug 02, 2021

SELL
$70.31 - $77.77 $21,585 - $23,875
-307 Reduced 4.38%
6,695 $521,000
Q1 2021

May 25, 2021

BUY
$68.86 - $81.11 $32,570 - $38,365
473 Added 7.24%
7,002 $540,000
Q4 2020

Feb 08, 2021

BUY
$71.77 - $79.65 $26,698 - $29,629
372 Added 6.04%
6,529 $509,000
Q3 2020

Nov 02, 2020

BUY
$73.18 - $82.95 $17,270 - $19,576
236 Added 3.99%
6,157 $487,000
Q2 2020

Aug 07, 2020

BUY
$70.42 - $80.13 $15,069 - $17,147
214 Added 3.75%
5,921 $480,000
Q1 2020

May 21, 2020

BUY
$63.36 - $87.82 $8,173 - $11,328
129 Added 2.31%
5,707 $419,000
Q4 2019

Feb 04, 2020

SELL
$77.58 - $87.54 $122,886 - $138,663
-1,584 Reduced 22.12%
5,578 $484,000
Q2 2019

Aug 07, 2019

BUY
$69.84 - $81.59 $500,194 - $584,347
7,162 New
7,162 $0
Q1 2019

May 10, 2019

SELL
$69.58 - $79.36 $12.4 Million - $14.1 Million
-177,671 Closed
0 $0
Q4 2018

Feb 06, 2019

BUY
$65.24 - $75.71 $796,710 - $924,570
12,212 Added 7.38%
177,671 $13 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $105,053 - $123,536
1,821 Added 1.11%
165,459 $11.7 Million
Q2 2018

Aug 06, 2018

SELL
$50.83 - $59.72 $167,027 - $196,239
-3,286 Reduced 1.97%
163,638 $0
Q1 2018

May 04, 2018

BUY
$50.96 - $59.23 $288,739 - $335,597
5,666 Added 3.51%
166,924 $0
Q4 2017

Jan 29, 2018

SELL
$51.62 - $61.64 $1.79 Million - $2.13 Million
-34,609 Reduced 17.67%
161,258 $9.07 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $703,981 - $757,496
11,999 Added 6.53%
195,867 $12.5 Million
Q2 2017

Aug 09, 2017

BUY
N/A
183,868
183,868 $11.8 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Capital Advisors Inc Portfolio

Follow Capital Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors Inc with notifications on news.